What is Beam Therapeutics Inc. Common Stock's Market Cap?

Beam Therapeutics Inc. Common Stock's Market Cap is $2.8B, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's Enterprise Value?

Beam Therapeutics Inc. Common Stock's Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's Price / Sales?

Beam Therapeutics Inc. Common Stock's Price / Sales is 17.8×, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's EV / Revenue?

Beam Therapeutics Inc. Common Stock's EV / Revenue is 11.1×, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's EV / EBITDA?

Beam Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's Revenue (TTM)?

Beam Therapeutics Inc. Common Stock's Revenue (TTM) is $156.0M, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's Net Income (TTM)?

Beam Therapeutics Inc. Common Stock's Net Income (TTM) is -$86.5M, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's EBITDA?

Beam Therapeutics Inc. Common Stock's EBITDA is -$355.8M, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Beam Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.84, based on as-reported figures from SEC (XBRL) filings.

What is Beam Therapeutics Inc. Common Stock's EBITDA Margin?

Beam Therapeutics Inc. Common Stock's EBITDA Margin is -228.0%, based on as-reported figures from SEC (XBRL) filings.

Beam Therapeutics Inc. Common Stock (BEAM) Financial Statements

Beam Therapeutics Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00KXC8655

XNAS · usd

26.90▲ 0.07 (0.26%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close26.83

Day's Range25.04 – 27.30

52-Week Range19.36 – 38.26

Volume6.2M

Avg Volume1.7M

Share Statistics

Shares Outstanding

Employees511

ExchangeXNAS

Listed2020-02-06

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Beam Therapeutics Inc. Common Stock (BEAM)

What is Beam Therapeutics Inc. Common Stock's Market Cap?: Beam Therapeutics Inc. Common Stock's Market Cap is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's Enterprise Value?: Beam Therapeutics Inc. Common Stock's Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's Price / Sales?: Beam Therapeutics Inc. Common Stock's Price / Sales is 17.8×, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's EV / Revenue?: Beam Therapeutics Inc. Common Stock's EV / Revenue is 11.1×, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's EV / EBITDA?: Beam Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's Revenue (TTM)?: Beam Therapeutics Inc. Common Stock's Revenue (TTM) is $156.0M, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's Net Income (TTM)?: Beam Therapeutics Inc. Common Stock's Net Income (TTM) is -$86.5M, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's EBITDA?: Beam Therapeutics Inc. Common Stock's EBITDA is -$355.8M, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Beam Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.84, based on as-reported figures from SEC (XBRL) filings.
What is Beam Therapeutics Inc. Common Stock's EBITDA Margin?: Beam Therapeutics Inc. Common Stock's EBITDA Margin is -228.0%, based on as-reported figures from SEC (XBRL) filings.